1. Home
  2. TEVA vs QSR Comparison

TEVA vs QSR Comparison

Compare TEVA & QSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • QSR
  • Stock Information
  • Founded
  • TEVA 1901
  • QSR 1954
  • Country
  • TEVA Israel
  • QSR United States
  • Employees
  • TEVA N/A
  • QSR N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • QSR
  • Sector
  • TEVA Health Care
  • QSR
  • Exchange
  • TEVA Nasdaq
  • QSR Nasdaq
  • Market Cap
  • TEVA 21.2B
  • QSR 20.6B
  • IPO Year
  • TEVA N/A
  • QSR 2006
  • Fundamental
  • Price
  • TEVA $19.08
  • QSR $67.63
  • Analyst Decision
  • TEVA Strong Buy
  • QSR Buy
  • Analyst Count
  • TEVA 7
  • QSR 20
  • Target Price
  • TEVA $25.57
  • QSR $75.32
  • AVG Volume (30 Days)
  • TEVA 9.0M
  • QSR 2.2M
  • Earning Date
  • TEVA 11-05-2025
  • QSR 10-30-2025
  • Dividend Yield
  • TEVA N/A
  • QSR 3.68%
  • EPS Growth
  • TEVA N/A
  • QSR N/A
  • EPS
  • TEVA N/A
  • QSR 2.63
  • Revenue
  • TEVA $16,628,000,000.00
  • QSR $9,106,000,000.00
  • Revenue This Year
  • TEVA $4.37
  • QSR $11.54
  • Revenue Next Year
  • TEVA $0.67
  • QSR $3.84
  • P/E Ratio
  • TEVA N/A
  • QSR $25.53
  • Revenue Growth
  • TEVA 2.08
  • QSR 21.80
  • 52 Week Low
  • TEVA $12.47
  • QSR $58.71
  • 52 Week High
  • TEVA $22.80
  • QSR $73.71
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 45.80
  • QSR 55.88
  • Support Level
  • TEVA $18.83
  • QSR $67.10
  • Resistance Level
  • TEVA $19.19
  • QSR $68.15
  • Average True Range (ATR)
  • TEVA 0.44
  • QSR 1.05
  • MACD
  • TEVA -0.15
  • QSR -0.12
  • Stochastic Oscillator
  • TEVA 13.53
  • QSR 40.48

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About QSR Restaurant Brands International Inc.

Restaurant Brands International is one of the largest restaurant companies in the world, with approximately USD 44 billion in 2024 systemwide sales across a footprint that spanned more than 32,000 restaurants and more than 100 countries. The firm generates revenue primarily from retail sales at its company-owned restaurants, royalty fees and lease income from franchised stores, and from its Tim Hortons supply chain operations. Formed in 2014 after 3G Capital's acquisition of Tim Hortons International, the RBI portfolio is split among Burger King (7,082 units), Tim Hortons (4,539 units), Popeyes Louisiana Kitchen (3,520 units), Firehouse Subs (1,345 units), and international franchise units of those banners (15,639) as of year-end 2024.

Share on Social Networks: